WeVote

Bill

Bill

SB 1035

Opioid antagonists; dispensing and administration by person acting on behalf of an organization.

2025 Regular Session Introduced by Chris Head and 1 co-sponsor

Virginia law now allows organizations to stock and administer naloxone without individual prescriptions, expanding overdose response access across schools, workplaces, and community settings effective July 1, 2025.

Acts of Assembly Chapter text (CHAP0386)
0
WeVote Research Nonpartisan
Bill Summary · SB 1035

Legislative bill overview

SB 1035 expands access to opioid antagonists (like naloxone/Narcan) by allowing organizations and their authorized representatives to dispense and administer these life-saving drugs without requiring individual prescriptions. The bill removes certain liability barriers and streamlines the process for making naloxone available in community settings, workplaces, schools, and other organizational contexts.

Why is this important

Opioid overdoses remain a leading cause of accidental death, and rapid access to naloxone can reverse overdose effects within minutes. By allowing organizations to stock and administer naloxone without prescription barriers, the law potentially saves lives by making the drug more accessible in emergencies. This addresses a critical gap where prescriptions or medical licensing requirements previously limited broader distribution.

Potential points of contention

  • Liability concerns: Organizations may worry about legal exposure if naloxone is misused, administered incorrectly, or causes adverse reactions, even with liability protections included
  • Implementation gaps: Schools, nonprofits, and small organizations may lack training resources or clarity on proper storage, administration protocols, and staff authorization procedures
  • Prescription drug regulation: Some medical professionals may question whether removing prescription requirements sets a precedent that could affect oversight of other controlled or regulated medications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.